Chaired by:
Michael W. Washabaugh, PhD
The MITRE Corporation
Maureen A. Costello, PhD
Costello Consulting, LLC
Martin Vanderlaan, PhD
Vanderlaan Consulting
Anthony S. Lubiniecki, ScD
A L Associates, LLC
Michaela Wendeler, PhD
AstraZeneca
Topics
- Reducing Production Costs
- Transients to Expedite Stable Cell Lines
- Securing Additional Capacity
- Accelerating Product Development
- Front Loading Analytical Characterization
- Challenges with Bispecific & Higher Antibodies
- Antibody Drug Conjugates
- Alternate Host Cell Platforms
- Cold-Chain Management
- Pandemic Preparation
- Lessons Learned & Emerging Best Practices
- Developability Assessment & Sequence Liability
- Antibody Lead Discovery
- High Concentration Formulations
- Prophylactic vs. Therapeutic Applications